Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 CHF | +13.33% | +10.39% | +107.32% |
Mar. 21 | Ascom Hires New CFO | MT |
Feb. 08 | Spexis Completes CHF2 Million Sale of Antibiotics Program to Basilea | MT |
Sales 2021 | 331 366.87 | Sales 2022 | 1.48M 1.64M | Capitalization | 19.96M 22.13M |
---|---|---|---|---|---|
Net income 2021 | -11M -12.19M | Net income 2022 | -18M -19.95M | EV / Sales 2021 * | - |
Net cash position 2021 | 6.23M 6.91M | Net Debt 2022 | 4.23M 4.69M | EV / Sales 2022 | 16.4 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-1.07
x | Employees | 28 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 46.61% |
Latest transcript on Spexis AG
1 day | +13.33% | ||
1 week | +10.39% | ||
Current month | -48.48% | ||
1 month | -44.63% | ||
3 months | +107.32% | ||
6 months | -69.86% | ||
Current year | +107.32% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Wager
CEO | Chief Executive Officer | 62 | 21-12-29 |
Martin Jakobovic
DFI | Director of Finance/CFO | - | - |
Stephan Wehselau
COO | Chief Operating Officer | 55 | 21-12-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Hartman
BRD | Director/Board Member | 62 | 21-12-29 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-12-29 |
Kuno Sommer
BRD | Director/Board Member | 68 | 12-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.085 | +13.33% | 198,276 |
24-03-27 | 0.075 | -2.60% | 332,111 |
24-03-26 | 0.077 | 0.00% | 31,358 |
24-03-25 | 0.077 | 0.00% | 272,226 |
24-03-22 | 0.077 | 0.00% | 53,915 |
Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+107.32% | 6.39M | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |